The global demand for B-Nicotinamide Mononucleotide Market is presumed to reach the market size of nearly USD XX MN by 2028 from USD XX MN in 2021 with a CAGR of XX% under the study period 2022 - 2028.
B-Nicotinamide mononucleotide (NMN) is a molecule that exists naturally in all living things. It is an intermediate of NAD+ biosynthesis produced from nicotinamide through nicotinamide phosphoribosyltransferase (NAMPT) and is also known as NMN or nicotinamide ribotide. B-Nicotinamide mononucleotide is mainly used to develop dietary supplements and other healthcare products. This could be utilised in animal feed or human diet to promote growth and immunity. B-Nicotinamide mononucleotide has been shown to prevent age-related gene expression alterations, improve metabolism, physical activity, insulin sensitivity, eye function, and suppress age-related weight gain.
Market Dynamics
The B- nicotinamide mononucleotide (NMN) has gained attention as a good anti-ageing health product among several anti-ageing health products. The food sector is fueling the increase in demand for NMN owing to growing concerns about meeting daily nutritional requirements through the use of processed foods. Moreover, the growing health awareness among people regarding their own fitness and well-being is fueling the market. Furthermore, the desire to look young among people is boosting the demand for NMN. Additionally, based on the anti-ageing properties of nicotinamide mononucleotide (NMN), several nations have also developed NMN face creams, NMN facial masks, and other cosmetic goods. This has caused the market demand for nicotinamide mononucleotide to expand quickly (NMN). Along with this, B-Nicotinamide mononucleotide is a green extraction of NMN, a kind of green technology that is non-toxic and harmless, has excellent absorption, and brings cost efficiency to the market.
The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of b-nicotinamide mononucleotide. The growth and trends of b-nicotinamide mononucleotide industry provide a holistic approach to this study.
Market Segmentation
This section of the b-nicotinamide mononucleotide market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.
By Type
- Content <98%
- Content ≥98%
By Application
- Health Care Products
- Cosmetics
- Others
Regional Analysis
This section covers the regional outlook, which accentuates current and future demand for the B-Nicotinamide Mononucleotide market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.
Global B-Nicotinamide Mononucleotide Market Share by Region (Representative Graph)
The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the b-nicotinamide mononucleotide market include GeneHarbor, Herbalmax, Genex Formulas, Shinkowa Pharmaceutical, Maac10 Formulas, EffePharm, Bontac, CELFULL, Kingdomway. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.
In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.